Skip to content

The Influence of Heat-sensitive Moxibustion on Cancer-Related Fatigue and Inflammatory Cytokines in Patients with Colorectal Cancer Undergoing Chemotherapy

The Influence of Heat-sensitive Moxibustion on Cancer-Related Fatigue and Inflammatory Cytokines in Patients with Colorectal Cancer Undergoing Chemotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002498
Enrollment
Unknown
Registered
2025-12-24
Start date
2025-06-20
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Control Group:Basic treatment + health education + chemotherapy
Treatment group:Basic treatment + Health education + Chemotherapy + Heat-sensitive moxibustion

Sponsors

Guangdong Provincial Hospital of Integrated Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria for colorectal cancer and cancer-related fatigue (both traditional Chinese medicine and Western medicine), have undergone relevant surgical treatments, and are currently undergoing postoperative chemotherapy for cancer-related fatigue, aged between 30 and 75 years, with no restrictions on gender; (3) Patients with a Karnofsky Performance Status (KPS) score of =60 and an estimated survival period exceeding 3 months; (4) Patients with a moderate fatigue score (4-6 points) on the 10-point numerical rating scale (NRS) screening for fatigue; (5) Patients with normal mental status, cooperative behavior, clear speech, and the ability to accurately express the sensation of moxibustion; (6) Patients who voluntarily participate in the study, sign the informed consent form, and have good compliance; (7) Patients who have not used drugs for the treatment of cancer-related fatigue or other traditional Chinese medicine therapies, or have discontinued such treatments for cancer-related fatigue and other traditional Chinese medicine therapies for more than 2 weeks.

Exclusion criteria

Exclusion criteria: (1) Pregnant or breastfeeding women; (2) Patients with severe primary diseases of the heart, brain, liver, kidneys, hematopoietic system, endocrine system, or immune system; (3) Patients with severe diabetes or uncontrolled blood sugar levels in the past three months; (4) Patients with skin damage on the chest or abdomen, or those allergic to moxa smoke or ginger; (5) Patients currently participating in other research studies or undergoing other interventions; (6) Patients with mental health issues.

Design outcomes

Primary

MeasureTime frame
Chronic disease treatment-related fatigue functional assessment scale(FACIT-F);Cytokine levels;

Secondary

MeasureTime frame
TCM Syndrome Score;Nutritional Risk Index(NRI);Hemoglobin level;

Countries

China

Contacts

Public ContactLiu Jingwen

Guangdong Provincial Hospital of Integrated Chinese and Western Medicine

13535530435@163.com13535530435

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026